AI-generated from publicly available materials.Stockholm-based Tandem Health has successfully secured €86.49 million ($100 million) in Series B funding to develop an AI-native operating system tailored for European healthcare. This funding round, led by the Scaleup Europe Fund, marks a significant milestone in the company's journey, which has now totaled €138.38 million ($160 million) since its inception.
Tandem Health, founded in 2023, aims to address the pressing challenges faced by European healthcare systems, including rising costs and clinician shortages. The company is developing a comprehensive AI medical assistant designed to streamline the workflow for clinicians throughout the entire patient experience. This includes preparing patient summaries, offering clinical decision support during consultations, and automating documentation processes post-visit.
The startup distinguishes itself by being the only AI medical assistant with independently certified components, including an AI scribe and coding assistant, recognized as Class IIa medical devices under EU regulations. This certification underscores the company's commitment to providing safe and reliable AI solutions that clinicians can trust, positioning Tandem as a key player in the evolving European healthcare landscape.
With plans to expand its clinician-led team and enhance its AI capabilities, Tandem Health aims to evolve from a medical assistant to a comprehensive clinic operating system. The company's growth trajectory and innovative approach could potentially redefine how AI is integrated into healthcare across Europe, enabling more efficient patient care while alleviating administrative burdens for healthcare providers.